Zenas BioPharma, Inc. (ZBIO) NASDAQ
17.40
+0.27(+1.58%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.62B |
| Enterprise Value | 1.59B |
| P/E Ratio | -2.28 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.88 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | -1.68 |
Income Statement
| Revenue | 10M |
| Revenue/Share | 0 |
| Gross Profit | 10M |
| EBITDA | -370.43M |
| Net Income | -377.74M |
| Diluted EPS | -8.44 |
Balance Sheet
| Total Cash | 717.21M |
| Total Cash/Share | 12.89 |
| Total Debt | 351.73M |
| Total Debt/Equity | 1.05 |
| Current Ratio | 11.94 |
| Book Value Per Share | 6.04 |
Price History
| 52-Week Change | 82.2 |
| 52-Week High | 44.6 |
| 52-Week Low | 8.91 |
| Moving Average 50 Days | 19.8 |
| Moving Average 200 Days | 24.59 |
Statistics
| Average Volume | 683,429 |
| Shares Outstanding | 44.64M |
| % Held by Institutions | 123.85 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
